Perspective Therapeutics (CATX) Receivables - Accured (2022 - 2025)
Perspective Therapeutics (CATX) posted Receivables - Accured of $1.0 million for Q4 2025, up 16.25% sequentially from $880000.0 in Q4 2024, and up 16.25% YoY from $880000.0 in Q4 2024.
Perspective Therapeutics (CATX) Receivables - Accured (2022 - 2025) Analysis & Trends
Perspective Therapeutics has reported Receivables - Accured for 3 years, with the latest figure at $1.0 million in Q4 2025.
- Quarterly Receivables - Accured rose 16.25% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (up 16.25% YoY) and the FY2025 annual result came in at $1.0 million, up 16.25% from the prior year.
- Receivables - Accured climbed to $1.0 million in Q4 2025 per CATX's latest filing, from $880000.0 in the prior quarter.
- Over five years, Receivables - Accured peaked at $1.0 million in Q4 2025 and troughed at $109000.0 in Q4 2022.
- A 3-year average of $670666.7 and a median of $880000.0 in 2024 frame the typical range for Receivables - Accured.
- The widest YoY moves for Receivables - Accured: up 16.25% in 2025, down 16.25% in 2025.
- Over 3 years, Receivables - Accured stood at $109000.0 in 2022, then surged by 707.34% to $880000.0 in 2024, then advanced by 16.25% to $1.0 million in 2025.
- According to Business Quant data, Receivables - Accured over the past three periods registered $1.0 million, $880000.0, and $109000.0 for Q4 2025, Q4 2024, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | - |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | - |
| 10 | Perspective Therapeutics | 388.50 Mn | 388.50 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.02 Mn |
| Dec 31, 2025 | 1.02 Mn |
| Dec 31, 2024 | 880,000.00 |
| Dec 31, 2024 | 880,000.00 |
| Dec 31, 2022 | 109,000.00 |
| Dec 31, 2022 | 109,000.00 |